Combination of Cytokine Hemosorption and High-volume Hemofiltration in Acute Pancreatitis

Recruiting N/A Interventional Study
Acute Pancreatitis Without Necrosis or Infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Efferon JSC · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Mortality from severe acute pancreatitis reaches 42%. The prognosis of acute pancreatitis is associated with the development of acute inflammatory response syndrome (SIRS) and multiple organ failure (MOF). Due to the lack of etiological therapy, the treatment of acute pancreatitis is predominantly symptomatic. Severity and mortality are associated with early systemic inflammatory response syndrom…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age from 18 to 75 years old, * Acute pancreatitis according to the Atlanta classification of OP (2012), without signs of infection, * Acute pancreatitis confirmed by tomography. Score according to the Modified CTSI Pancreatitis Severity Index: from 4 points and above, * No mor…
Contacts

Alexandr Shelehov-Kravchenko, PhD, MD

+79636564765

alexandr.shelehov@gmail.com

CONTACT